Your global issues news reporter
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
4 hours ago
Health Matters: Air travel
an hour ago
Artemis II: It’s not for science
As featured in:
@ Journalists!
Join
Simon Jessop
REUTERS.COM
Eileen Guo
TECHNOLOGYREVIEW.COM
Lyse Doucet
BBC.CO.UK
Peter Jones
MUCKRACK.COM
Press releases
Publish your press release
4 hours ago
Top Talking Pen Manufacturer Advances Smart Education Technology With AI-Enabled Learning Solutions
EIN Presswire
SHENZHEN, GUANGDONG, CHINA, May 7, 2026 /EINPresswire.com/ -- In the global education technology sector, Shenzhen Xuezhiyou Technology Co., Ltd. has been recognized as one of the notable contributors to the development of smart learning tools...
2 hours ago
Man & Science Appoints Prof. Jean-Pierre Van Buyten as Chief Medical Officer
EIN Presswire
Leading neuromodulation expert joins Man & Science to guide clinical strategy as company advances ONS study and next-generation injectable PNS platform LIèGE, BELGIUM, May 7, 2026 /EINPresswire.com/ -- Man & Science SA, a privately held medical...
3 hours ago
SGI Global HQ Launches in U.S., Driving Tech Innovation & Capital Evolution
EIN Presswire
CHICAGO, IL, UNITED STATES, May 7, 2026 /EINPresswire.com/ -- At a pivotal moment when human civilization is advancing into an intelligent era, and at the historic intersection where technological revolution and capital structures are being...
14 hours ago
Launch of New HVAC Training Technology at Goodwin Tech Highlights Historic Industry Partnership and Workforce Investment
Connecticut Technical Education And Career System
New Britain, CT — Students at E.C. Goodwin Technical High School are gaining hands-on experience with cutting-edge HVAC technology thanks to a new industry-supported training system unveiled during an event held on Wednesday, May 6. The...
2 hours ago
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
GlobeNewswire, Inc.
The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration of approximately 4.1 billion USD, representing...
4 hours ago
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
GlobeNewswire, Inc.
The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration of approximately 4.1 billion USD, representing...
Video Stories
Discover Affinity Group Publishing
Sign up for:
World Post Reporter
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
